[Federal Register: February 7, 2003 (Volume 68, Number 26)]
[Notices]
[Page 6483-6488]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07fe03-78]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 03027]
Grants for New Investigator Training Awards for Unintentional
Injury, Violence Related Injury, Acute Care, Disability, and
Rehabilitation-Related Research
Application Deadline: April 8, 2003.
A. Authority and Catalog of Federal Domestic Assistance Number
This program is authorized under section 301 (a) (42 U.S.C. 241(a))
of the Public Health Service Act, and section 391 (a) (42 U.S.C. 280b
(a)) of the Public Service Health Act, as amended. The catalog of
Federal Domestic Assistance number is 93.136.
B. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 2003 funds for grants for new
investigator training awards in four research areas: unintentional
injury prevention, violence-related injury prevention, injury-related
acute care and disability research, and injury-related biomechanics
research. This program addresses the ``Healthy People 2010'' focus
areas of Injury and Violence Prevention.
The purposes of this program are to:
1. Solicit research applications that address the priorities
reflected under the ``Program Requirements'' section.
2. Encourage professionals from a wide spectrum of disciplines of
engineering, epidemiology, medicine, biostatistics, public health, law
and criminal justice, and behavioral, and social sciences to perform
research in order to prevent and control injuries more effectively.
3. Support injury research by recent doctoral-level graduates or
researchers who are redirecting their careers toward injury research.
4. Build the scientific base for the prevention and control of
unintentional and violence-related injuries, disabilities, and deaths.
5. Encourage qualified applicants who are beginning or redirecting
their career to focus on injury-related research. The career
development objectives of this program are to encourage scientists to
develop independent research skills and to gain experience in advanced
methods and experimental approaches in injury-related research. This
program is also intended to jump start the careers of researchers in
injury prevention and control by providing support for pilot studies,
enhancements to existing studies, or other studies that will serve as a
foundation for a career in injury prevention and control. Applicants
are required to seek mentoring or collaboration for their research with
more senior-level injury researchers.
Measurable outcomes of the program will be in alignment with the
performance goal for the National Center for Injury Prevention and
Control (NCIPC): Develop new or improved approaches for preventing and
controlling death and disability due to injuries.
Background and Significance
1. Unintentional Injury Prevention Research
For the purposes of this RFA, unintentional injuries are defined as
unintentional damage to the body resulting from acute exposure to
thermal, mechanical, electrical, or chemical energy or from the absence
of such essentials as heat or oxygen. Unintentional injuries continue
to be a major public health problem. In 1999, nearly 98,000 people died
in the United States as a result of unintentional injuries. Someone
dies in this country every six minutes from an injury that is within a
category of injuries that includes: motor vehicle crashes, falls,
poisonings, drowning, fires and burns, pedestrians struck by motor
vehicles, bicycle crashes, or suffocation. In addition to deaths,
injuries also constitute a significant cause of both permanent and
temporary disability. In 2000, unintentional injuries resulted in
nearly 30 million emergency department visits and millions more visits
to physicians' offices. Although the greatest cost of injury is human
pain and suffering, the financial costs also are staggering: over 200
billion dollars annually for medical care, wage and productivity losses
and employer costs in 1998.
[[Page 6484]]
2. Violence Related Injury Prevention Research
Deaths and injuries associated with interpersonal violence and
suicidal behavior are also a major public health problem in the U.S.
and around the world. In 1999, over 46,000 people died from homicide
and suicide in the U.S. Among 15 to 24 year olds, homicide and suicide
ranked as the second and the third leading causes of death. Violent
deaths are the most visible consequence of violent behavior in our
society. Morbidity associated with physical and emotional injuries and
disabilities resulting from violence, however, also constitute an
enormous public health problem. For every homicide that occurs each
year there are over 100 nonfatal injuries resulting from interpersonal
violence. For every completed suicide it is estimated that there are 20
to 25 suicide attempts. The mortality and morbidity resulting from
violence are associated with a variety of types of violence including
child maltreatment, youth violence, intimate partner violence, sexual
violence, elder abuse, and self-directed violence or suicidal behavior.
3. Injury Related Acute Care, Disability, and Rehabilitation
Each year, Americans make between 30 and 40 million emergency
department (ED) visits for injuries. While most injured patients are
treated and released, many are admitted to inpatient trauma units and
later receive rehabilitative services. The most favorable outcomes are
achieved when acute care and subsequent rehabilitation are as early as
possible and focus on returning patients to baseline or to an optimal
level of functioning. Trauma systems are designed to match trauma
patients with the acute care and rehabilitative facilities they need,
but in many parts of the U.S. trauma systems are not fully operational
or are nonexistent. Also, as many as 30 to 40 percent of deaths among
trauma patients are due to preventable problems in clinical care,
including missed diagnoses and treatment delays.
Injuries are a major cause of disabilities in the U.S. Central
nervous system injuries (those to the brain and spinal cord) are most
likely to result in serious long-term disability. Each year, an
estimated 80,000 Americans sustain a traumatic brain injury (TBI) that
results in disability; an estimated 5.3 million Americans live with
TBI-related disability. Although physical impairments from the injury
may contribute to TBI disability, cognitive deficits are the hallmark,
frequently resulting in secondary conditions such as depression and
other adverse outcomes such as the inability to work. An estimated
177,000 to 200,000 people in the U.S. live with spinal cord injuries
(SCI), and this number increases annually by as many as 20,000
individuals.
4. Biomechanics
The field of biomechanics quantifies the response and tolerance of
the human body to impact (e.g., motor vehicle collisions, playground
falls, and child battering) and addresses the underlying mechanisms of
injury, the forces deforming the body and the physiologic effects of
injury to infants, children, adults and the aged population. Based on
interdisciplinary research, the engineering factors are determined that
deform the body and the medical consequences are quantified that affect
vital functions. This knowledge is used to modify the design of
protective systems to improve safety. Improved safety systems protect
an individual from impact forces that can injure, and they can include
protective equipment (cycling helmets) and environments (playground
surfaces), occupant restraints (airbags and safety belts), and policies
(rules to minimize spearing in football). Biomechanical knowledge can
also be used to improve post-injury outcomes through physiologic models
to address emergency medical treatments, pharmacologic interventions
and rehabilitation to advance recovery.
An overview of the role of biomechanics in a national effort for
injury control was included in the landmark NAS study ``Injury in
America: A Continuing Public Health Problem-Committee on Trauma
Research'' (Commission on Life Sciences, National Research Council and
the Institute of Medicine, National Academy Press, Washington, DC,
1985). The role is described in more detail in a follow-on paper from
the NAS study: Injury Biomechanics Research: An Essential Element in
the Prevention of Trauma (Viano DC, King AI, Melvin JW, Weber K.
Journal of Biomechanics, 22(5): 403-417, 1989).
This program attempts to build on the basic knowledge of
biomechanics and encourage interdisciplinary intervention-oriented
injury control research as supported in the ``CDC Injury Research
Agenda'' (See Attachment 2 as posted on the CDC Web site).
C. Eligible Applicants
Applications may be submitted by public and private nonprofit and
for profit organizations and by governments and their agencies; that
is, universities and colleges (including but not limited to schools or
departments of public health, medicine, nursing, criminal justice,
bioengineering, or the behavioral or social sciences,) technical
schools, research institutions, hospitals, other public and private
nonprofit and for profit organizations, community-based organizations,
faith-based organizations, State and local governments or their bona
fide agents, including the District of Columbia, the Commonwealth of
Puerto Rico, the Virgin Islands, the Commonwealth of the Northern
Mariana Islands, American Samoa, Guam, the Federated States of
Micronesia, the Republic of the Marshall Islands, and the Republic of
Palau, Federally recognized Indian tribal governments, Indian tribes,
or Indian tribal organizations, and small, minority, and/or women-owned
businesses.
Note: Title 2 of the United States Code section 1611 states that
an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant or loan.
Applicants must have a research or a health-professional doctorate-
level degree from an accredited program and have demonstrated the
capacity or potential for highly productive research in the period
after the doctorate, commensurate with level of experience. Applicants
must be within three years of having completed their doctoral or
equivalent graduate work (including dissertation, where appropriate),
or redirecting their research to injury-related research. Documentation
of such redirection such as letters indicating recent substantive
involvement in injury research or injury-related publications must be
included in the application. Applicants who have been the principal
investigator on a Public Health Service (PHS) injury-related research
grant or who have had equivalent injury-related research support from
an existing Injury Control Research Center (ICRC) are not eligible.
Exceptions are researchers who have redirected their research areas
from one area of injury research, e.g., acute care or biomechanics, to
another area, e.g., violence prevention research. Recipients of
dissertation research grants or National Institutes of Health (NIH)
Small Grant Awards are eligible to apply.
Applications that are incomplete or non-responsive to the following
requirements will be returned to the applicant without further
consideration:
[[Page 6485]]
1. A principal investigator who has specific authority and
responsibility to carry out the proposed project.
2. Effective and well-defined working relationships within the
performing organization and with outside entities, which will ensure
implementation of the proposed activities.
3. The ability to carry out injury control research projects as
defined under Attachment 2 (1. a-c) as posted on the CDC website.
4. The overall match between the applicant's proposed theme and
research objectives and the program priorities as described under the
heading, ``Program Requirements''.
5. Mentorship as noted in the letter of support and commitment of
mentor's time.
D. Funding
Availability of Funds
Approximately $400,000 is available in FY 2003 to fund
approximately four awards. It is expected that the award will begin on
or about September 1, 2003, and will be made for a 12-month project
period. Grants will be awarded for 12 months, but may be extended
without additional funds for up to a total of 24 months. The maximum
funding level for each project will not exceed $100,000 (direct and
indirect costs) per year. Funding estimates may change.
Applications that exceed the funding caps noted above will be
excluded from the competition and returned to the applicant. The
availability of federal funding may vary and is subject to change.
Note: Grant funds will not be made available to support the
provision of direct care. Eligible applicants may enter into
contracts, including consortia agreements, as necessary to meet the
requirements of the program and strengthen the overall application.
Use of Funds
The use of funds for applicant include, partial salary and tuition
support; direct research project expenses, such as trainee stipends,
interviewer costs, data processing, participant incentives, statistical
consultation services, and supplies; and travel to one scientific
meeting, if adequately justified. Applicants should also include travel
costs for one, two-day trip to CDC in Atlanta to present research
findings. Funds for tuition support are limited to no more than 20
percent of the overall award and their use must be generally related to
the content and methods of the proposed research. Indirect cost for
these trainee-related activities are limited to eight percent.
Recipient Financial Participation
Matching funds are not required for this program.
E. Program Requirements
Applicants are encouraged to propose studies that can feasibly be
completed within the available funds and funding period.
Research Objectives
For the purpose of this Program Announcement, highest consideration
will be given to research that addresses one of the following research
areas and subtopics:
Violence
1. Evaluation of strategies for disseminating and implementing
evidence-based interventions or policies for the prevention of intimate
partner violence, sexual violence (includes both sexual violence
against adults and child sexual abuse), child maltreatment, youth
violence or suicidal behavior.
2. Evaluation of the efficacy, effectiveness, and cost
effectiveness of interventions, programs, and policies to prevent
intimate partner violence, sexual violence, child maltreatment, youth
violence or suicidal behavior.
3. Identification of shared and unique risk and protective factors
for the perpetration of intimate partner violence, sexual violence,
child maltreatment, youth violence or suicidal behavior, and examine
the relationships among these forms of violence.
Unintentional Injury
1. Development of strategies that encourage practitioners and
policy makers to adopt science-based programs, policies, laws, and
regulations that reduce unintentional injuries.
2. Identification of modifiable behavioral responses to a
residential fire and evaluating the effectiveness of evacuation
strategies in fire emergencies and mass trauma events.
3. Among children, determination of the immediate causes of the
most severe and disabling types of falls, or evaluating interventions
that prevent serious falls in children.
4. Development of interventions that utilize applied behavioral
analysis, behavioral safety, or other behavior modification strategies
to change injury risk behaviors in non-occupational settings.
5. Development and implementation of interventions to increase
motor vehicle safety in older adult drivers.
6. Evaluation of the effectiveness of implementing new innovative
strategies to reduce alcohol-impaired driving.
7. Evaluation of the effectiveness of environmental, engineering or
behavioral interventions to prevent pedestrian injury.
8. Methodological research to better define and measure aspects of
supervision and its relative effectiveness in preventing injuries
Acute Care, Disability, and Rehabilitation
1. Development and evaluation of protocols that provide onsite
interventions in acute care settings or linkages to off-site services
for patients at risk of injury or psychosocial problems following
injury.
2. Development and application of methods that can be used to
calculate population-based estimates of the incidence, costs, and long-
term consequences of spinal cord injury (SCI) and nonhospitalized
traumatic brain injury (TBI). Identification of methods and strategies
to ensure that people with TBI and SCI receive needed services.
Biomechanics
1. Use of biomechanics research and the knowledge of injury
tolerance and injury mechanisms for the development and evaluation of
interventions that address the following specific injury prevention and
control problems:
a. Falls among older, community dwelling adults (e.g., hip pads).
b. Injuries in mass trauma events.
c. Severe and disabling falls among children.
d. Sports, recreation, and exercise related injuries (e.g.,
playground and other play environments, safety gear).
e. Injuries associated with people initiating or increasing
physical activity (e.g., training programs or protective devices).
f. Injuries related to outdoor recreation (e.g., vehicle design).
g. Motorcycling, bicycling and pedestrian injuries (e.g., vehicle
design).
h. Injuries to child occupants of motor vehicles (e.g., universal
fasteners and alternative restraint designs).
i. Injuries to older drivers.
j. Injuries associated with the effects of emerging vehicle
technologies.
2. Development of more basic biomechanical information that is
needed to identify biomechanics and specific injuries that would be
highly predictive of diagnoses of intimate partner violence and child
maltreatment and improve case definitions.
3. Advancement of the biomechanical understanding of traumatic
injury (e.g., injuries to the brain, spinal cord, thorax/
[[Page 6486]]
abdomen, extremities and joints) including the development of
biofidelic models to elucidate injury physiology as well as
pharmacologic, surgical, rehabilitation, and other interventions;
improvement of injury assessment technology; impact injury mechanisms
research; and quantification of injury-related biomechanical responses
for critical areas of the human body (e.g., brain and vertebral injury
with spinal cord involvement).
4. Definition of the human tolerance limits for injury, especially
determining the differences in human tolerance by age, fitness level,
and gender and the biomechanics and injury tolerances of tissue, bone,
and other human structures as a prerequisite for developing
interventions.
5. Identification of the modifiable risk factors for and mechanisms
of nonfatal neck, back, and soft tissue (whiplash-like) injuries.
Other Special Conditions for New Investigator Research Grants
1. The applicant must be the designated principal investigator. The
principal investigator must be responsible for planning, directing, and
executing the proposed project. The applicant must include a signed
letter indicating that he or she personally wrote the application.
2. The applicant must specify which of four areas the proposal
addresses: (a) Unintentional injury; (b) violence-related injury
research; (c) injury-related acute care, disability, and
rehabilitation; or (d) biomechanics.
3. The applicant must provide measures of effectiveness that will
demonstrate the accomplishment of the various identified objectives of
the grant. Measures must be objective/quantitative and must measure the
intended outcome. These measures of effectiveness must be submitted
with the application and will be an element of the application
evaluation.
4. The grant may not be transferred to another institution, except
under unusual and compelling circumstances (such as if the mentor moves
to a new institution and both the mentor and the applicant wish to move
together).
5. Any publications directly resulting from the grant should be
reported to the responsible CDC program official. The grantee also must
cite receiving support from HHS/CDC/NCIPC in any publications directly
resulting from the new investigator grant.
F. Content
Letter of Intent (LOI)
The LOI is optional for this program. The narrative should be no
more than single-spaced pages, printed on one side, with one-inch
margins, and unreduced 12-point font. Your letter should identify the
announcement number, the name of the principal investigator, and
briefly describe the scope and intent of the proposed research work.
The letter of intent does not influence review or funding decisions,
but the number of letters received will enable CDC to plan the
application review more effectively and efficiently.
Applications
The Program Announcement title and number must appear in the
application. Use the information in the Program Requirements, Other
Requirements, and Evaluation Criteria sections to develop the
application content. Your application will be evaluated on the criteria
listed, so it is important to follow them in laying out your program
plan. The narrative should be no more than 25 single-spaced pages,
printed on one side, with one-inch margins, and unreduced 12-point
font.
Applications should follow the PHS-398 (Rev. 5/2001) application
and Errata sheet, and the narrative should include the following
information:
1. The project's focus that justifies the research needs and
describes the scientific basis for the research, the expected outcome,
and the relevance of the findings to reduce injury morbidity,
mortality, disability, and economic losses. This focus should be based
on recommendations in ``Healthy People 2010'' and the ``CDC Injury
Research Agenda'' and should seek creative approaches that will
contribute to a national program for injury control.
2. Specific, measurable, and time-framed objectives.
3. A detailed plan, which describes the methods by which the
objectives will be achieved, including their sequence. A comprehensive
evaluation plan is an essential component of the application.
4. A description of the roles and responsibilities of the principal
investigator and mentor, where appropriate.
5. A description of all project staff regardless of their funding
source. It should include their title, qualifications, experience,
percentage of time each will devote to the project, as well as that
portion of their salary to be paid by the grant.
6. A description of those activities related to, but not supported
by the grant.
7. A description of the involvement of other entities that will
relate to the proposed project, if applicable. It should include
letters of organizational commitments of support and a clear statement
of their roles.
8. A detailed budget for the grant.
9. An explanation of how the research findings will contribute to
the national effort to reduce the morbidity, mortality and disability
caused by injuries.
10. An evaluation plan for the project, including quantifiable
measures of effectiveness.
Additional Materials Required
In addition to the completed PHS 398 application form, the
applicant must also submit the following materials, attached to the
application as appendices:
1. An official transcript of the applicant's graduate school
record, if within the last three years.
2. When relevant, documentation showing the researcher has
redirected his or her career within the last three years.
3. A justification for any proposed tuition support.
4. An overview of the applicant's prior research training and
experience as well as a statement of the applicant's short-term and
long-term research and career goals and intended career trajectory.
5. A letter from the applicant's mentor or scientific collaborator
that outlines the proposed plan for providing scientific advice and
consultation to the applicant during the grant period and a biography
of the mentor or senior-level collaborator, limited to two pages (Use
the Biographical Sketch page in application form PHS 398.)
G. Submission and Deadline
Letter of Intent (LOI) Submission
On or before March 4, 2003, submit the LOI to the Grants Management
Specialist identified in the ``Where to Obtain Additional Information''
section of this announcement.
Application Forms
Submit the original and two copies of PHS-398 (OMB Number 0925-
0001). Forms are available at the following Internet address:
www.cdc.gov/od/pgo/forminfo.htm.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) at 770-488-2700, and forms can be mailed to you.
Submission Date, Time, and Address
The application must be received by 4 p.m. eastern time, April 8,
2003.
[[Page 6487]]
Submit the application to: Technical Information Management--PA 03027,
Procurement and Grants Office, Centers for Disease Control Prevention,
2920 Brandywine Rd, Room 3000, Atlanta, GA 30341-4146.
Applications may not be submitted electronically.
CDC Acknowledgement of Application Receipt
A postcard will be mailed by PGO-TIM, notifying you that CDC has
received your application.
Deadline
Letters of intent and applications shall be considered as meeting
the deadline if they are received before 4 p.m. eastern time on the
deadline date. Any applicant who sends their application by the United
States Postal Service or commercial delivery services must ensure that
the carrier will be able to guarantee delivery of the application by
the closing date and time. If an application is received after closing
due to (1) carrier error, when the carrier accepted the package with a
guarantee for delivery by the closing date and time, or (2) significant
weather delays or natural disasters, CDC will upon receipt of proper
documentation, consider the application as having been received by the
deadline.
Any application that does not meet the above criteria will not be
eligible for competition and will be discarded. Applicants will be
notified of their failure to meet the submission requirements.
H. Evaluation Criteria
Application
Upon receipt, applications will be reviewed by CDC staff for
completeness, responsiveness, and eligibility as outlined under the
``Eligible Applicants'' section. Incomplete applications and
applications that are not responsive will be returned to the applicant
without further consideration.
It is especially important that the applicant's abstract reflects
the project's focus, because the abstract will be used to help
determine the responsiveness of the application.
Applications which are complete and responsive may be subjected to
a preliminary evaluation (streamline review) by a peer review
committee, the Injury Research Grant Review Committee (IRGRC), to
determine if the application is of sufficient technical and scientific
merit to warrant further review by the IRGRC; CDC will withdraw from
further consideration applications judged to be noncompetitive and
promptly notify the principal investigator/program director and the
official signing for the applicant organization. Those applications
judged to be competitive will be further evaluated by a dual review
process.
All awards will be determined by the Director of the NCIPC based on
priority scores assigned to applications by the IRGRC, recommendations
by the secondary review committee, e.g., NCIPC's Advisory Committee for
Injury Prevention and Control (ACIPC), consultation with NCIPC senior
staff, and the availability of funds.
1. The primary review will be a peer review conducted by the IRGRC.
A committee consisting of no less than three reviewers with appropriate
expertise using current NIH criteria (a scoring system of 100-500
points) will evaluate the methods and scientific quality of the
application. All categories are of equal importance, however, the
application does not need to be strong in all categories to be judged
likely to have a major scientific impact.
Factors to be considered will include:
a. Significance--Does this study address an important problem? If
the aims of the application are achieved, how will scientific knowledge
be advanced? What will be the effect of these studies on the concepts
or methods that drive this field?
b. Approach--Are the conceptual framework, design, methods, and
analyses adequately developed, well integrated, and appropriate to the
aims of the project and the resources available? Does the applicant
acknowledge potential problem areas and consider alternative tactics?
Does the project include plans to measure progress toward achieving the
stated objectives? Is there an appropriate work plan included?
c. Innovation--Does the project employ novel concepts, approaches
or methods? Are the aims original and innovative? Does the project
challenge or advance existing paradigms, or develop new methodologies
or technologies?
d. Investigator--Is the principal investigator appropriately
trained and well suited to carry out this work? Is the proposed work
appropriate to the experience level of the principal investigator? Is
the name and role of a scientific mentor or collaborator described?
e. Environment--Does the scientific environment in which the work
will be done contribute to the probability of success? Is there
evidence of institutional support? Is there an appropriate degree of
commitment and cooperation of other interested parties as evidenced by
letters detailing the nature and extent of the involvement?
f. Ethical Issues. What provisions have been made for the
protection of human subjects and the safety of the research
environments? Where relevant, how does the applicant plan to handle
issues of confidentiality and compliance with mandated reporting
requirements, e.g., suspected child abuse? Does the application
adequately address the requirements of 45 CFR part 46 for the
protection of human subjects? (An application can be disapproved if the
research risks are sufficiently serious and protection against risks is
so inadequate as to make the entire application unacceptable.) The
degree to which the applicant has met the CDC Policy requirements
regarding the inclusion of women, ethnic, and racial groups in the
proposed research (see Attachment 1, AR-2). This includes:
(1) The proposed plan for the inclusion of both sexes and racial
and ethnic minority populations for appropriate representation.
(2) The proposed justification when representation is limited or
absent.
(3) A statement as to whether the design of the study is adequate
to measure differences when warranted.
(4) A statement as to whether the plans for recruitment and
outreach for study participants include the process of establishing
partnerships with community(ies) and recognition of mutual benefits.
g. Study Samples. Are the samples sufficiently rigorously defined
to permit complete independent replication at another site? Have the
referral sources been described, including the definitions and
criteria? What plans have been made to include women and minorities,
and their subgroups as appropriate for the scientific goals of the
research? How will the applicant deal with recruitment and retention of
subjects?
h. Dissemination. What plans have been articulated for
disseminating findings?
i. Measures of Effectiveness. The Peer Review Panel shall assure
that measures set forth in the application are in accordance with CDC's
performance plans. How adequately has the applicant addressed these
measures?
The IRGRC will also examine the appropriateness of the proposed
project budget and duration in relation to the proposed research and
the availability of data required for the project.
2. The secondary review will be conducted by the Science and
Program Review Subcommittee (SPRS) of the ACIPC. The ACIPC Federal
agency experts will be invited to attend the
[[Page 6488]]
secondary review, and will receive modified briefing books (i.e.,
abstracts, strengths and weaknesses from summary statements, and
project officer's briefing materials). ACIPC Federal agency experts
will be encouraged to participate in deliberations when applications
address overlapping areas of research interest, so that unwarranted
duplication in federally funded research can be avoided and special
subject area expertise can be shared. The NCIPC Division Associate
Directors for Science (ADS) or their designees will attend the
secondary review in a similar capacity as the ACIPC Federal agency
experts to assure that research priorities of the announcement are
understood and to provide background regarding current research
activities. Only SPRS members will vote on funding recommendations, and
their recommendations will be carried to the entire ACIPC for voting by
the ACIPC members in closed session. If any further review is needed by
the ACIPC, regarding the recommendations of the SPRS, the factors
considered will be the same as those considered by the SPRS.
The committee's responsibility is to develop funding
recommendations for the NCIPC Director based on the results of the
primary review, the relevance and balance of proposed research relative
to the NCIPC programs and priorities, and to assure that unwarranted
duplication of federally funded research does not occur. The secondary
review committee has the latitude to recommend to the NCIPC Director,
to reach over better-ranked proposals in order to assure maximal impact
and balance of proposed research. The factors to be considered will
include:
a. The results of the primary review including the application's
priority score as the primary factor in the selection process.
b. The relevance and balance of proposed research relative to the
NCIPC programs and priorities.
c. The significance of the proposed activities in relation to the
priorities and objectives stated in ``Healthy People 2010,'' the
Institute of Medicine report, ``Reducing the Burden of Injury,'' and
the ``CDC Injury Research Agenda'.
I. Other Requirements
Technical Reporting Requirements
Provide CDC with an original plus two copies of:
1. Annual progress report (The progress report will include a data
requirement that demonstrates measures of effectiveness).
2. A financial status report, no more than 90 days after the end of
the budget period.
3. A final financial report and performance report, no more than 90
days after the end of the project period.
4. At the completion of the project, the grant recipient will
submit a brief (2,500 to 4,000 words written in non-scientific
(laymen's) terms) summary highlighting the findings and their
implications for injury prevention programs, policies, environmental
changes, etc. The grant recipient will also include a description of
the dissemination plan for research findings. This plan will include
publications in peer-reviewed journals and ways in which research
findings will be made available to stakeholders outside of academia,
(e.g., state injury prevention program staff, community groups, public
health injury prevention practitioners, and others). CDC will place the
summary report and each grant recipient's final report with the
National Technical Information Service (NTIS) to further the agency's
efforts to make the information more available and accessible to the
public.
Send all reports to the Grants Management Specialist identified in
the ``Where to Obtain Additional Information'' section of this
announcement.
Additional Requirements
The following additional requirements are applicable to this
program. For a complete description of each, see Attachment 1 of the
program announcement as posted on the CDC web site.
AR-1 Human Subjects Certification
AR-2 Requirements for inclusion of Women and Racial and Ethnic
Minorities in Research
AR-3 Animal Subjects Requirement
AR-9 Paperwork Reduction Requirements
AR-10 Smoke-Free Workplace Requirement
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-13 Prohibition on Use of CDC funds for Certain Gun Control
Activities
AR-21 Small, Minority, and Women-owned Business
AR-22 Research Integrity
Executive Order 12372 does not apply to this program.
J. Where To Obtain Additional Information
This and other CDC announcements, the necessary applications, and
associated forms can be found on the CDC web site, Internet address:
http://www.cdc.gov.
Click on ``Funding,'' then ``Grants and Cooperative Agreements.''
For general questions about this announcement, contact: Technical
Information Management, CDC Procurement and Grants Office, 2920
Brandywine Rd, Atlanta, GA 30341-4146. Telephone: 770-488-2700.
For business management and budget assistance, contact: Richard
Jenkins, Grants Management Specialist, Procurement and Grants Office,
Centers for Disease Control and Prevention, 2920 Brandywine Road,
Atlanta, GA 30341-4146. Telephone: 770-488-2604. E-mail address:
rbj3@cdc.gov.
For program technical assistance, contact: Tom Voglesonger, Program
Manager, Office of the Director, National Center for Injury Prevention
and Control, Centers for Disease Control and Prevention (CDC), 4770
Buford Highway, NE., Mailstop K-02, Atlanta, GA 30341-3724. Telephone:
770-488-4823. Internet address: TVoglesonger@cdc.gov.
Dated: February 1, 2003.
Sandra R. Manning,
CGFM, Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 03-3027 Filed 2-6-03; 8:45 am]
BILLING CODE 4163-18-P